| Unlock ST Premium FREE Trial: Discover top stock picks & smart tools | |
| Good morning! US stocks moved higher in premarket trading Thursday, with Dow futures rising 0.71%, S&P 500 futures gaining 0.81%, and Nasdaq-100 futures advancing 1.07% after Wednesday’s selloff. Investor sentiment improved following the Federal Reserve’s 25-basis-point rate hike, its first increase in three years, with policymakers projecting one additional hike this year. Hawkish comments from Fed Chair Kevin Warsh were viewed by analysts as reinforcing the central bank’s inflation-fighting credibility. Meanwhile, oil prices edged lower as expectations grew that Saudi Arabia’s East-West pipeline would soon be restored. Brent crude traded near $104 per barrel. Investors also awaited US jobless claims, housing starts, and the Bank of England’s policy decision. | |
|
Top 5 Digital Assets Set to Surge Through 2025–2026
Inside, you’ll discover:
- ✅ How institutional capital is reshaping the crypto landscape
- ✅ Five digital assets positioned to benefit from the next growth wave
- ✅ Smart strategies for early positioning before mainstream momentum builds
👉 Access Your Free Report Here
By following the links above, you’re opting in to receive valuable updates from Wealthiest Investor News plus 2 bonus subscriptions. Your privacy is important to us. You can unsubscribe anytime. See our privacy policy for details.
Sponsored
| |
|
Datasea Intelligent Technology Ltd (DTSS) stock soared 25.74% to $0.74 in pre-market trading after announcing plans to expand its partnership with Linghang Intelligent to develop AI-powered elderly care robots and digital services.
Vicor Corp (NASDAQ: VICR) shares are trading up 12.53% at $206.95 at the time of writing after announcing a new licensing agreement for its Vertical Power Delivery (VPD) modules.
Ainos Inc (AIMD) grew over 9.50% to $1.51 in pre-market trading today after a research update highlighted growing commercial momentum for its AI Nose platform, supported by semiconductor orders, subscription revenue, and a dataset exceeding 1 billion records.
Propanc Biopharma Inc (PPCB) jumped about 8.35% to $0.68 in pre-market trading Thursday after releasing a comparative analysis of its PRP candidate against leading RAS-targeted cancer treatments.
| |
|
Wall Street just bet billions on a small collection of stocks… And it looks like they’re about to bet even more.
Our analysts have tracked the rotation and identified 10 companies getting heavy accumulation from the big money.
Our 10 Best Stocks to Own in 2026 report lays out the tickers, the trends, and why these names are attracting fresh capital right now.
Don’t wait until the headlines hit.
Send My Free Report
Sponsored
| |
| Top Upgrades & Downgrades | |
|
UBS turned bullish on Union Pacific Corp (UNP), upgrading the stock to Buy and assigning a $339 price target, representing potential upside of 20.67% from Wednesday's close.
Alvotech SA (ALVO) has won the favor of Barclays's equity research team. The firm upgraded the shares from Underweight to Overweight and moved its price target to $8, suggesting 56.86% additional upside for the stock.
Credicorp Ltd (BAP) received an upgrade from analysts at Morgan Stanley, who also set their one-year price target on the stock to $480. They changed their rating on BAP to Overweight from Equal-Weight in a recently issued research note.
Truist reduced its rating on Meritage Homes Corp (MTH) stock to Hold from Buy and assigned the price target to $72.
Mizuho analysts reduced their investment ratings, saying in research reports covered by the media that its rating for Hartford Insurance Group Inc (HIG) has been changed to Neutral from Outperform and the new price target is set at $154.
Analysts at Barclays downgraded Cellectis SA (CLLS) stock to Underweight from Overweight, and the new price target is set at $1.
| |
|
Terawulf Inc (WULF) Director, Bucella Michael C. declared the purchase of shares taking place on Sep 15 '26 at $14.79 for some 6085 shares. The transaction amount was around $89,967.
Solidion Technology, Inc (STI) Chief Financial Officer, Prantsevich Vlad bought on Sep 14 '26 a total of 1030 shares at $7.13 on average. The purchase cost the insider an estimated $7,344.
BOSTON OMAHA Corp (BOC) Director, Keating Brendan Joseph announced the sale of shares taking place on Sep 15 '26 at $13.56 for some 100994 shares. The total came to more than $1.37 million.
Landmark Bancorp Inc (LARK) Director, LEWIS JIM sold on Sep 15 '26 a total 400 shares at $32.92 on average. The insider’s sale generated proceeds of almost $13,168.
| |
|
Dear Investor,
The space industry is moving rapidly from experimentation to commercialization, and 2026 is shaping up to be a defining year for investors. Record launch activity, falling costs, supportive government policy, and new technologies like satellite constellations and orbital AI are transforming space into a scalable, revenue-generating industry. The 7 Best Space Stocks to Own in 2026 explains why this shift matters now—and how it’s creating a new wave of investable opportunities.
This report profiles seven companies positioned across the core layers of the modern space economy, including launch services, satellite manufacturing, communications, data platforms, defense-backed operators, and in-space infrastructure. Each company breakdown focuses on what the business does, how it makes money, and the key growth catalysts and risks to watch in 2026 and beyond. The analysis is clear, practical, and grounded in real operating performance rather than speculation.
The report also addresses the big questions driving investor interest, including the potential impact of a SpaceX or Starlink IPO and where the most attractive risk-reward opportunities may lie. Whether you’re seeking high-growth exposure or more stable, cash-generating space investments, this report provides the insight needed to navigate an industry that may be on the verge of moving from niche theme to mainstream growth opportunity.
Get Your Copy of "The 7 Best Space Stocks To Own In 2026" Here.
Sponsored
| |
|
Top US Upcoming earnings releases scheduled include Upexi, Inc (UPXI). It will announce its June 2026 financial results. The company is expected to report earnings of -$0.11 per share from revenues of $5.8M in the three-month period.
Analysts expect Abivax SA (ABVX) to report a net income (adjusted) of -$0.86 per share when the company releases its quarterly results. Revenue for the fiscal quarter ended June 2026 is predicted to come in at $814.89k.
| |
| That's it for today. Thanks for reading. Good luck out there! Best Regards, Stocks Telegraph Team | |
| Disclaimer: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside of these emails. | |
|
